Matt Miksic Analyst Performance

Equity Research Analyst, Medical Supplies and Devices at Barclays

Matt Miksic is a stock analyst at Barclays focused in the medical sector, covering 29 publicly traded companies. Over the past year, Matt Miksic has issued 37 stock ratings, including buy, hold, and sell recommendations. While full access to Matt Miksic's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Matt Miksic's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Analyst Ranking

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

111 Last 11 Years

Buy Recommendations

81.82% 90 Buy Ratings

Companies Covered

29 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.9%	1 ratings
Buy	80.9%	89 ratings
Hold	15.5%	17 ratings
Sell	2.7%	3 ratings

Out of 110 total stock ratings issued by Matt Miksic at Barclays, the majority (80.9%) have been Buy recommendations, followed by 15.5% Hold, 2.7% Sell, and 0.9% Strong Buy.

Best & Worst Calls

• Best Call

  0000.0%

  ORGO

  Mar 2020

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  ALC

  Mar 2020

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NASDAQ	55.2% of companies on NASDAQ	16 companies
NYSE	44.8% of companies on NYSE	13 companies

Matt Miksic, an analyst at Barclays, currently covers 29 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 28 companies	96.6%
	Miscellaneous 1 company	3.4%

Matt Miksic of Barclays specializes in stock coverage within the Medical sector, with additional focus on companies.

Coverage Industries

Industry	Percentage
MED PRODUCTS 9 companies	31.0%
MED INSTRUMENTS 9 companies	31.0%
MEDICAL SERVICES 2 companies	6.9%
MED/DENTAL - SUPP 2 companies	6.9%
PROCESS CONTROL INSTRUMENTS 1 company	3.4%
MED - BIOMED/GENE 1 company	3.4%
LARGE CAP PHARMA 1 company	3.4%
MED - DRUGS 1 company	3.4%
MEDICAL DEVICES 1 company	3.4%
SURGICAL & MEDICAL INSTRUMENTS 1 company	3.4%
Miscellaneous 1 company	3.4%

Matt Miksic's Ratings History at Barclays

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
SENS Senseonics	8/27/2025	Initiated Coverage	$0.46	$1.50	Overweight	$0.00 00.00% ROI
HUMA Humacyte	8/27/2025	Initiated Coverage	$1.47	$3.50	Overweight	$0.00 00.00% ROI
HUMA Humacyte	8/27/2025	Initiated Coverage	$1.58	$3.50	Overweight	$0.00 00.00% ROI
SENS Senseonics	8/27/2025	Initiated Coverage	$0.46	$1.50	Overweight	$0.00 00.00% ROI
PODD Insulet	8/21/2025	Boost Price Target	$330.83	$300.00	Equal Weight	$0.00 00.00% ROI
LIVN LivaNova	8/21/2025	Boost Price Target	$53.30	$58.00	Equal Weight	$0.00 00.00% ROI
TNDM Tandem Diabetes Care	8/8/2025	Lower Price Target	$11.44	$51.00	Overweight	$0.00 00.00% ROI
ATEC Alphatec	8/4/2025	Reiterated Rating	$14.39	$22.00	Overweight	$0.00 00.00% ROI
BAX Baxter International	8/4/2025	Lower Price Target	$22.41	$36.00	Overweight	$0.00 00.00% ROI
INMD InMode	7/30/2025	Lower Price Target	$14.02	$21.00	Overweight	$0.00 00.00% ROI
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
DXCM DexCom	7/30/2025	Boost Price Target	$89.81	$98.00	Equal Weight	$0.00 00.00% ROI
EW Edwards Lifesciences	7/25/2025	Boost Price Target	$79.41	$95.00	Overweight	$0.00 00.00% ROI
BSX Boston Scientific	7/24/2025	Boost Price Target	$107.51	$133.00	Overweight	$0.00 00.00% ROI
ZIMV ZimVie	7/22/2025	Upgrade	$18.77	$19.00	Equal Weight	$0.00 00.00% ROI
JNJ Johnson & Johnson	7/17/2025	Boost Price Target	$162.77	$176.00	Equal Weight	$0.00 00.00% ROI
BLCO Bausch + Lomb	6/9/2025	Lower Price Target	$11.86	$16.00	Equal Weight	$0.00 00.00% ROI
BDX Becton, Dickinson and Company	6/3/2025	Lower Price Target	$169.26	$241.00	Overweight	$0.00 00.00% ROI
LIVN LivaNova	5/8/2025	Lower Price Target	$44.44	$55.00	Equal Weight	$0.00 00.00% ROI
DXCM DexCom	5/5/2025	Boost Price Target	$81.62	$93.00	Equal Weight	$0.00 00.00% ROI
INMD InMode	4/30/2025	Lower Price Target	$13.96	$24.00	Overweight	$0.00 00.00% ROI
PODD Insulet	4/30/2025	Boost Price Target	$252.29	$266.00	Equal Weight	$0.00 00.00% ROI
BSX Boston Scientific	4/25/2025	Boost Price Target	$101.13	$125.00	Overweight	$0.00 00.00% ROI
ISRG Intuitive Surgical	4/24/2025	Lower Price Target	$508.13	$635.00	Overweight	$0.00 00.00% ROI
ABT Abbott Laboratories	4/17/2025	Boost Price Target	$130.64	$159.00	Overweight	$0.00 00.00% ROI
JNJ Johnson & Johnson	4/17/2025	Lower Price Target	$157.99	$165.00	Equal Weight	$0.00 00.00% ROI
LIVN LivaNova	3/7/2025	Lower Price Target	$39.99	$56.00	Equal Weight	$0.00 00.00% ROI
TNDM Tandem Diabetes Care	2/28/2025	Lower Price Target	$22.14	$53.00	Overweight	$0.00 00.00% ROI
GMED Globus Medical	2/24/2025	Boost Price Target	$80.43	$103.00	Overweight	$0.00 00.00% ROI
BAX Baxter International	2/20/2025	Initiated Coverage	$33.35	$39.00	Overweight	$0.00 00.00% ROI
EW Edwards Lifesciences	2/13/2025	Boost Price Target	$75.73	$90.00	Overweight	$0.00 00.00% ROI
BSX Boston Scientific	2/10/2025	Boost Price Target	$105.33	$118.00	Overweight	$0.00 00.00% ROI
ZBH Zimmer Biomet	2/10/2025	Lower Price Target	$101.01	$112.00	Underweight	$0.00 00.00% ROI
SYK Stryker	2/10/2025	Boost Price Target	$391.42	$443.00	Overweight	$0.00 00.00% ROI
INMD InMode	2/5/2025	Boost Price Target	$17.50	$29.00	Overweight	$0.00 00.00% ROI
JNJ Johnson & Johnson	1/28/2025	Boost Price Target	$152.91	$166.00	Equal Weight	$0.00 00.00% ROI
ABT Abbott Laboratories	1/27/2025	Reiterated Rating	$125.12	$158.00	Overweight	$0.00 00.00% ROI
ATEC Alphatec	1/22/2025	Boost Price Target	$11.61	$21.00	Overweight	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.